C G M Erkens1, A G Dinmohamed1, M Kamphorst2, S Toumanian3, R van Nispen-Dobrescu4, M Alink5, N Oudshoorn6, M Mensen7, S van den Hof1, M Borgdorff7, S Verver1. 1. KNCV Tuberculosis Foundation, The Hague, The Netherlands. 2. Public Health Service Rotterdam Rijnmond, Rotterdam, The Netherlands. 3. GGD Twente, Enschede, The Netherlands. 4. GGD Brabant Zuidoost, Eindhoven, The Netherlands. 5. GGD Zuid Limburg, Heerlen, The Netherlands. 6. GGD Den Haag, Den Haag, The Netherlands. 7. Public Health Services Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Interferon-gamma release assays (IGRAs) are reported to be more specific for the diagnosis of latent tuberculous infection (LTBI) than the tuberculin skin test (TST). The two-step procedure, TST followed by an IGRA, is reported to be cost-effective in high-income countries, but it requires more financial resources. OBJECTIVE: To assess the added value of IGRA compared to TST alone in the Netherlands. METHODS: Test results and background data on persons tested with an IGRA were recorded by the Public Municipal Health Services in a web-based database. The number of persons diagnosed with LTBI using different screening algorithms was calculated. RESULTS: In those tested with an IGRA, at least 60% of persons who would have been diagnosed with LTBI based on TST alone had a negative IGRA. Among those with a TST reaction below the cut-off for the diagnosis of LTBI, 13% had a positive IGRA. For 41% of persons tested with an IGRA after TST, the IGRA influenced whether or not an LTBI diagnosis would be made. CONCLUSION: With the IGRA as reference standard, a high proportion of persons in low-prevalence settings are treated unnecessarily for LTBI if tested with TST alone, while a small proportion eligible for preventive treatment are missed. Incremental costs of the two-step strategy seem to be balanced by the improved targeting of preventive treatment.
BACKGROUND:Interferon-gamma release assays (IGRAs) are reported to be more specific for the diagnosis of latent tuberculous infection (LTBI) than the tuberculin skin test (TST). The two-step procedure, TST followed by an IGRA, is reported to be cost-effective in high-income countries, but it requires more financial resources. OBJECTIVE: To assess the added value of IGRA compared to TST alone in the Netherlands. METHODS: Test results and background data on persons tested with an IGRA were recorded by the Public Municipal Health Services in a web-based database. The number of persons diagnosed with LTBI using different screening algorithms was calculated. RESULTS: In those tested with an IGRA, at least 60% of persons who would have been diagnosed with LTBI based on TST alone had a negative IGRA. Among those with a TST reaction below the cut-off for the diagnosis of LTBI, 13% had a positive IGRA. For 41% of persons tested with an IGRA after TST, the IGRA influenced whether or not an LTBI diagnosis would be made. CONCLUSION: With the IGRA as reference standard, a high proportion of persons in low-prevalence settings are treated unnecessarily for LTBI if tested with TST alone, while a small proportion eligible for preventive treatment are missed. Incremental costs of the two-step strategy seem to be balanced by the improved targeting of preventive treatment.
Authors: Christine S Ho; Pei-Jean I Feng; Masahiro Narita; Jason E Stout; Michael Chen; Lisa Pascopella; Richard Garfein; Randall Reves; Dolly J Katz Journal: Lancet Infect Dis Date: 2021-09-06 Impact factor: 25.071
Authors: G Suzanne A Smit; Ludwig Apers; Wouter Arrazola de Onate; Philippe Beutels; Pierre Dorny; An-Marie Forier; Kristien Janssens; Jean Macq; Ruud Mak; Sandrina Schol; Dirk Wildemeersch; Niko Speybroeck; Brecht Devleesschauwer Journal: Bull World Health Organ Date: 2016-11-03 Impact factor: 9.408
Authors: Tan N Doan; Damon P Eisen; Morgan T Rose; Andrew Slack; Grace Stearnes; Emma S McBryde Journal: PLoS One Date: 2017-11-28 Impact factor: 3.240
Authors: Ibrahim Abubakar; Francis Drobniewski; Jo Southern; Alice J Sitch; Charlotte Jackson; Marc Lipman; Jonathan J Deeks; Chris Griffiths; Graham Bothamley; William Lynn; Helen Burgess; Bobby Mann; Ambreen Imran; Saranya Sridhar; Chuen-Yan Tsou; Vladyslav Nikolayevskyy; Melanie Rees-Roberts; Hilary Whitworth; Onn Min Kon; Pranab Haldar; Heinke Kunst; Sarah Anderson; Andrew Hayward; John M Watson; Heather Milburn; Ajit Lalvani Journal: Lancet Infect Dis Date: 2018-08-30 Impact factor: 71.421